首页|西瑞香素通过调控谷胱甘肽过氧化物酶4和铁蛋白重链1表达对786-O细胞铁死亡、增殖及侵袭的影响

西瑞香素通过调控谷胱甘肽过氧化物酶4和铁蛋白重链1表达对786-O细胞铁死亡、增殖及侵袭的影响

扫码查看
目的 探讨西瑞香素(DAP)抑制肾细胞癌(RCC)细胞786-O的增殖、侵袭能力和诱导铁死亡的作用及分子机制.方法 采用不同浓度DAP(0、12.5、25.0、50.0、100.0μmol/L)处理786-O细胞后,细胞计数试剂盒(CCK-8)和Transwell检测细胞增殖和侵袭能力.12.5 µmol/L DAP联合铁死亡诱导剂(0.2 μmol/L Erastin或30 nmol/L RSL3)处理细胞24 h后,CCK-8检测细胞活力.12.5 µmol/L DAP与10.0 μmol/L铁螯合剂(DFO)或50 mg/L补铁剂(FAC)联合处理细胞24 h后,用总铁和Fe2+检测试剂盒分析总铁和Fe2+水平变化.用蛋白质印迹法(Western blot)检测各蛋白的表达.两组间比较用t检验,多组间比较用单因素方差分析.结果 CCK-8结果显示,0 μmol/L DAP组吸光度值高于 12.5、25、50.100 μmol/L 组(处理 24 h:0.10±0.15 比 0.85±0.12、0.79±0.11、0.78±0.12、0.65±0.10;处理 48 h:2.23±0.28 比 1.93±0.16、1.43±0.13、1.29±0.20、0.92±0.34).Transwell 结果显示,0 µmol/L DAP 组吸光度值高于 12.5、25、50、100 μmol/L 组(2.93±0.36 比 2.24±0.40、1.90±0.44、1.18±0.29、0.97±0.37,均 P<0.05).HK-2 细胞组的GPX4 蛋白相对表达量低于 786-O 细胞组(100%比 742%,F=40.48,P<0.01).0 μmol/L DAP 组GPX4蛋白灰度值高于12.5、25、50、100 μmol/L组(每组相对灰度值分别为1、0.84、0.81、0.73、0.49).CCK-8结果显示,DAP联合Erastin组吸光度值低于DAP和Erastin单独处理组[(1.61±0.46)L/(g·cm)比(2.43±0.11)L/(g·cm)和(2.38±0.41)L/(g·cm),均 P<0.05],同时,DAP联合RSL3组吸光度值低于DAP或RSL3单独处理组[(0.62±0.53)L/(g·cm)比(1.89±0.53)L/(g·cm)或(1.52±0.26)L/(g·cm),均 P<0.05].另外,DAP 联合 Erastin 或 RSL3 组GPX4蛋白灰度值低于control、DAP、Erastin或RSL3组(每组相对灰度值分别为0.71、0.46、1、0.92、0.84、1.18).786-O细胞组FTH1蛋白表达与HK-2细胞组间的差异无统计学意义(141.33%比100.00%,F=1.49,P>0.05).但是,0 μmol/L DAP 组 FTH1 蛋白灰度值高于 12.5、25、50、100 μmol/L组(每组相对灰度值分别为l、0.95、0.82、0.62、0.47).Fe2+水平检测结果显示,DFO组的 Fe2+水平低于 control 组和 DAP 组[(0.21±0.03)nmol/106 比(0.56±0.14)nmol/106 和(1.22±0.26)nmol/106,均 P<0.05];而 DAP+DFO 组的 Fe2+水平高于 DFO 组[(0.62±0.15)nmol/106 比(0.21±0.03)nmol/106,P<0.05].另外,0 μmol/L DAP组FoxO3a蛋白相对表达量低于其他浓度组(1.00 比 1.45±0.32,P>0.05;1.00 比 1.65±0.40、1.55±0.32、1.55±0.13,均 P<0.05);0 µmol/L DAP组pGSK-3β(Ser9)蛋白相对表达量高于其他浓度组(1.00比1.02±0.15,P>0.05;1.00 比 0.82±0.04、0.72±0.03、0.67±0.11,均 P<0.05),GSK-3β、TIGAR、KIF18A、PSMA/FOLHI/NAALADaseI蛋白在各组间表达差异无统计学意义(P>0.05).786-O细胞组GSK-3β和pGSK-3β 蛋白相对表达量低于 HK-2 细胞组[(58.00±3.00)%比 100%,F=588.00,P<0.01;(43.67±1.53)%比 100%,F=4 080.14,P<0.01],而 FoxO3a 蛋白相对表达量高于 HK-2 细胞组[(164.67±23.54)%比 100%,F=22.63,P<0.01].上调 pGSK-3β 组的 GPX4 和 FTH1 的蛋白表达与vector组比较差异无统计学意义(P>0.05).下调FoxO3a组的GPX4和FTH1蛋白相对表达量低于 shNC 组[GPX4:100%比(69.33±10.07)%、(48.00±10.82)%、(54.67±26.58)%和(29.33±6.43)%,F=10.87,均P<0.05;FTH1:100%比(90.33±33.25)%,P>0.05,100%比(64.67±16.26)%、(55.00±12.53)%和(48.00±13.23)%,F=4.49,均 P<0.05].DAP 组pGSK-3β蛋白灰度值低于shNC组,pcDNA3.1-GSK-3β组pGSK-3β蛋白灰度值高于shNC组和DAP组,pcDNA3.1-GSK-3β+DAP组pGSK-3β蛋白灰度值却未高于DAP组(GSK-3β相对灰度值分别为1.00、1.21、1.25、1.53;pGSK-3β 相对灰度值分别为 1.00、0.79、1.34、0.57).DAP 组 FoxO3a 蛋白灰度值高于shNC组,shFoxO3a-811和shFoxO3a-1 156组FoxO3a蛋白灰度值低于shNC组和DAP组,但是,联合组的FoxO3a蛋白灰度值却未低于DAP组(各组相对灰度值分别为1.00、1.36、0.52、1.33、0.81、1.27).结论 DAP通过抑制GPX4和FTH1蛋白表达、增加Fe2+水平诱导786-O细胞铁死亡进而抑制增殖和侵袭,但DAP并不直接调控pGSK-3β/FoxO3a途径.
Daphnoretin induces ferroptosis in 786-O cells by suppressing glutathione peroxidase 4 and FTH1 expression,thereby inhibiting cell proliferation and invasion independently of the GSK/FoxO3a pathway
Objective This study examines the effects of daphnoretin(DAP)on the proliferation and invasion of 786-O cells and its ability to induce ferroptosis,exploring the underlying molecular mecha-nisms.Methods The impact of DAP on 786-O cell proliferation and invasion was measured using cell counting kit-8(CCK-8)and Transwell assays at various concentrations(0,12.5,25.0,50.0,100.0 µmol/L).Additionally,cell viability was assessed with a CCK-8 assay following co-treatment with 0.2 µmol/L Erastin or 30.0 nmol/L RSL3 and 12.5 µmol/L DAP for 24 hours.Cells were also treated with 12.5 μmol/L DAP alongside 10 µmol/L deferoxamine(DFO)or 50 mg/L ferric ammonium citrate(FAC)for 24 hours,with subsequent measurement of total iron and Fe2+concentrations using assay kits.Protein expressions were analyzed via western blot.Statistical analysis involved t-tests for two-group com-parisons and one-way ANOVA for multiple groups.Results CCK-8 assays revealed that the absorbance values for the 0 µmol/L DAP group exceeded those of the 12.5,25,50,and 100 μmol/L groups after 24 and 48 h of treatment(0.10±0.15 vs.0.85±0.12,0.79±0.11,0.78±0.12,0.65±0.10,respec-tively;2.23±0.28 vs.1.93±0.16,1.43±0.13,1.29±0.20,0.92±0.34,respectively).Similarly,Transwell assays indicated higher absorbance values for the 0 μmol/L DAP group compared to the 12.5,25,50,and 100 μmol/L groups(2.93±0.36 vs.2.24±0.40,1.90±0.44,1.18±0.29,0.97±0.37,respectively;all P<0.05).GPX4 protein expression in HK-2 cells was significantly lower than in 786-O cells(100%vs.742%,F=40.48,P<0.01).The GPX4 protein expression in the 0 μmol/L DAP group exhibited higher relative gray values compared to the 12.5,25,50,and 100 µmol/L groups,with 1,0.84,0.81,0.73,and 0.49,respectively.The absorbance values for DAP combined with Erastin were lower than those observed with DAP or Erastin alone[(1.61±0.46)L/(g·cm)vs.(2.43±0.11)L/(g·cm)or(2.38±0.41)L/(g-cm),bothP<0.05].The combination of DAP and RSL3 resul-ted in lower absorbance compared to DAP or RSL3 alone[(0.62±0.53)L/(g·cm)vs.(1.89±0.53)L/(g-cm)or(1.52±0.26)L/(g-cm),bothP<0.05].Additionally,GPX4 protein expression was reduced in the DAP combined with Erastin or RSL3 groups compared to control,DAP,Erastin,or RSL3 groups(relative gray values of 0.71,0.46,1,0.92,0.84,and 1.18,respectively).No significant difference was found in FTH1 protein expression between the 786-O and HK-2 cell groups(141.33%vs.100%,F=1.49,P>0.05),though the gray value of FTH1 protein in the 0 µmol/L DAP group was higher than in the 12.5,25,50,and 100 μmol/L groups(relative gray values of 1,0.95,0.82,0.62,and 0.47,respectively).The results of Fe2+level assay showed that the Fe2+level in the DFO group was lower than that in the control and the DAP group[(0.21±0.03)nmol/106 vs.(0.56±0.14)nmol/106 and(1.22±0.26)nmol/106,all P<0.05].Whereas,the Fe2+level in the DAP+DFO group was high-er than that in the DFO group[(0.62±0.15)nmol/106 vs.(0.21±0.03)nmol/106,P<0.05].In ad-dition,the relative expression of FoxO3a protein in the 0 μmol/L DAP group was lower than that in the oth-er concentration groups(1.00 vs.1.45±0.32,P>0.05;1.00 vs.1.65±0.40,1.55±0.32,and 1.55±0.13,all P<0.05);the relative expression of pGSK-3[3(Ser9)protein in the 0 μmol/L DAP group was higher than that in the other concentration groups(1.00 vs.1.02±0.15,P>0.05;1.00 vs.0.82±0.04,0.72±0.03,0.67±0.11,all P<0.05),and GSK-3β,TIGAR,KIF18A,and PSMA/FOLH1/NAALADaseI proteins were expressed among the groups differences were not statistically significant(P>0.05).The relative expression of GSK-3β and pGSK-3β proteins in the 786-O cell group was lower than that in the HK-2 cell group[(58.00±3.00)%vs.100%,F=588,P<0.01;(43.67±1.53)%vs.100%,F=4080.14,P<0.01],whereas the relative expression of FoxO3a proteins was higher than that in the HK-2 cell group[(164.67±23.54)%vs.100%,F=22.63,P<0.01].The differences in protein expression of GPX4 and FTH1 in the up-regulated pGSK-3β group were not statistically significant compared with the vector group(P>0.05).The relative expression of GPX4 and FTH1 proteins in the down-regulated FoxO3a group was lower than that in the shNC group[GPX4:100%vs.(69.33±10.07)%,(48.00±10.82)%,(54.67±26.58)%and(29.33±6.43)%,F=10.87,all P<0.05;FTH1:100%vs.(90.33±33.25%P>0.05;100%vs.(64.67±16.26)%,(55.00±12.53)%and(48.00±13.23)%,F=4.49,all P<0.05].Importantly,the pGSK-3β protein gray value in the DAP group was smaller than that in the shNC group,and the pGSK-3β protein gray value in the pcDNA3.1-GSK-3β group was larger than that in the shNC and the DAP group;however,the pGSK-3β protein gray value in the pcDNA3.1-GSK-3β+DAP group was not larger than that in the DAP group(relative gray val-ues for GSK-3β were 1.00,1.21,1.25,1.53;pGSK-3β relative gray values were 1.00,0.79,1.34,0.57).The FoxO3a protein gray values of the DAP group were larger than those of the shNC group,and the FoxO3a protein gray values of the shFoxO3a-811 and shFoxO3a-1156 groups were smaller than those of the shNC and the DAP group,but the gray value of FoxO3a protein in the combined group was not smaller than that in the DAP group(relative gray values of the groups were 1.00,1.36,0.52,1.33,0.81,1.27).Conclusion DAP induces ferroptosis in 786-O cells by reducing GPX4 and FTH1 protein levels and increasing Fe2+concentrations,which suppresses cell proliferation and invasion.However,DAP does not appear to directly affect the pGSK-3β/FoxO3a signaling pathway.

DaphnoretinRenal cell carcinomaGlutathione peroxidase 4/Ferritin heavy chain 1Phosphorylated glycogen synthase kinase-3β/Forkhead box transcription factor 3aFerroptosisProliferation and Invasion

王雪、水豪杰、张曙伟、胡潇威、黄帅帅、翁国斌、宋灵敏

展开 >

宁波市鄞州区第二医院泌尿肾病研究所,宁波 315000

宁波市鄞州区第二医院门诊办公室,宁波 315000

宁波市鄞州区第二医院泌尿外科,宁波 315000

西瑞香素 肾细胞癌 谷胱甘肽过氧化物酶4/铁蛋白重链1 磷酸化糖原合成酶激酶-3β/叉头框转录因子3a 铁死亡 增殖和侵袭

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(11)